LEADER 01603nam  2200505   450 
001 9910466859303321
005 20210330215223.0
010   $a1-4963-8914-X
035   $a(CKB)4100000005043488
035   $a(MiAaPQ)EBC5944616
035   $a(EXLCZ)994100000005043488
100   $a20191122d2019      uy             0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aHandbook of targeted cancer therapy and immunotherapy /$fDaniel D. Karp, Gerald S. Falchook
205   $aSecond edition.
210  1$aPhiladelphia :$cWolters Kluwer,$d[2019]
210  4$dİ2019
215   $a1 online resource (319 pages)
300   $aIncludes index.
311   $a1-4963-8913-1 
606   $aCancer$xChemotherapy
606   $aMolecular Targeted Therapy$xmethods
606   $aNeoplasms$xdrug therapy
606   $aAntineoplastic Agents$xadministration & dosage
606   $aAntineoplastic Agents$xmetabolism
608   $aElectronic books.
615  0$aCancer$xChemotherapy.
615 12$aMolecular Targeted Therapy$xmethods.
615 12$aNeoplasms$xdrug therapy.
615 22$aAntineoplastic Agents$xadministration & dosage.
615 22$aAntineoplastic Agents$xmetabolism.
676   $a616.994061
700   $aKarp$b Daniel D.$01033306
702   $aFalchook$b Gerald S.
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910466859303321
996   $aHandbook of targeted cancer therapy and immunotherapy$92451782
997   $aUNINA